Our VaR model is consistent with the regulatory measure of market risk capital and has been approved by the Swiss Federal
Banking Commission (SFBC), our main regulator.
The majority of our trading activities fall under the definition of "trading book" for regulatory capital treatment. This
means that both general and idiosyncratic market risks in these books are subject to a market risk capital requirement. It
also means that the securities and other exposures to single names in tradable form are not generally subject to "banking
book" capital requirements, which are typically higher. If a trading position in such an asset ceases to be eligible for trading
book treatment (for example if it becomes illiquid), it must be underpinned by capital on a banking book basis, but it remains
subject to the market risk control framework for internal control purposes.
In first quarter 2006, the SFBC approved the inclusion of our base metals and soft commodities derivatives trading business
in VaR for regulatory capital purposes. It was included in both our external disclosure and our market risk regulatory capital
from 15 March 2006, but its incremental impact was minimal.
All non-trading foreign exchange exposures (other than structural positions see "Treasury Management" chapter) are included
in VaR for regulatory capital purposes. There are some non-material legacy commodities positions in the form of warrants for
which the market risk capital requirement is calculated using the "standardized method" prescribed by regulation. Other non-trading
general market risks (interest rate and equity) are not subject to a market risk capital charge but interest rate risk which
is not included in VaR for regulatory capital purposes is reported to Swiss regulators.
Further explanation of regulatory capital treatment is provided in note 29 of our Financial Report 2006.